Biological and analytical characterization of two extracts from Valeriana officinalis

被引:38
|
作者
Circosta, Clara [1 ]
De Pasquale, Rita [1 ]
Samperi, Stefania [1 ]
Pino, Annalisa [1 ]
Occhiuto, Francesco [1 ]
机构
[1] Univ Messina, Sch Pharm, Pharmacobiol Dept, Vill SS Annunziata, I-98168 Messina, Italy
关键词
Valeriana officinalis; anticoronaryspastic; antihypertensive; antibronchospastic; calcium-channel blockade;
D O I
10.1016/j.jep.2007.03.021
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The anticoro nary spastic and anti bronchospastic activities of ethanolic and aqueous extracts of Valeriana officinalis L. roots were investigated in anaesthetized guinea-pigs and the results were correlated with the qualitative/quantitative chemical composition of the extracts in order to account for some of the common uses of this plant. The protective effects of orally administered ethanolic and aqueous extracts (50, 100 and 200 mg/kg) were evaluated against pitressin-induced coronary spasm and pressor response in guinea-pigs and were compared with those of nifedipine. Furthermore, the protective effects against histamine-induced and Oleaceae antigen challenge-induced bronchospasm were evaluated. Finally, the two valerian extracts were analytically characterized by qualitative and quantitative chromatographic analysis. The results showed that the two valeriana extracts possessed significant anticoronary spastic, antiltypertensive and antibronchospastic properties. These were similar to those exhibited by nifedipine and are due to the structural features of the active principles they contain. This study justifies the traditional use of this plant in the treatment of some respiratory and cardiovascular disorders. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 50 条
  • [1] Neuroprotective properties of Valeriana officinalis extracts
    Malva, JO
    Santos, S
    Macedo, T
    NEUROTOXICITY RESEARCH, 2004, 6 (02) : 131 - 140
  • [2] Updating the biological interest of Valeriana officinalis
    Sanchez, Marta
    Burgos, Elena Gonzalez
    Iglesias, Irene
    Gomez-Serranillos, M. Pilar
    MEDITERRANEAN BOTANY, 2021, 42
  • [3] Effects of extracts from Valeriana officinalis L. in pharmacological studies
    Hattesohl, M.
    Feistel, B.
    Sievers, H.
    Lehnfeld, R.
    Winterhoff, H.
    PLANTA MEDICA, 2006, 72 (11) : 1064 - 1064
  • [4] Two New Iridoids from the Roots of Valeriana officinalis
    Zhao, You-Xing
    Wang, Peng-Cheng
    Ran, Xin-Hui
    Ma, Qing-Yun
    Li, Ning
    Liu, Yu-Qing
    Zhou, Jun
    JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2011, 58 (05) : 659 - 662
  • [5] ANALYTICAL AND PHARMACOLOGICAL ASPECTS OF ESSENTIAL OIL FROM VALERIANA-OFFICINALIS
    HENDRIKS, H
    GEERTSMA, HJ
    ALLERSMA, D
    BOS, R
    MALINGRE, TM
    KOSTER, AS
    PLANTA MEDICA, 1981, 42 (02) : 131 - 131
  • [6] PHARMACOLOGICAL INVESTIGATION OF CERTAIN VALERIANA OFFICINALIS L EXTRACTS
    ROSECRANS, J
    YOUNGKEN, HW
    DEFEO, JJ
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1961, 50 (03) : 240 - &
  • [7] The effects of the extracts of Valeriana officinalis L. on cardiac arrhythmias
    Wen, Li
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 168P - 168P
  • [8] Characterization of two geraniol synthases from Valeriana officinalis and Lippia dulcis: Similar activity but difference in subcellular localization
    Dong, Lemeng
    Miettinen, Karel
    Goedbloed, Miriam
    Verstappen, France W. A.
    Voster, Alessandra
    Jongsma, Maarten A.
    Memelink, Johan
    van der Krol, Sander
    Bouwmeester, Harro J.
    METABOLIC ENGINEERING, 2013, 20 : 198 - 211
  • [9] Effects of Valeriana officinalis extracts on [3H]glutamate binding
    Hernanadez, Bianca A. Torres
    Gonzalez-Medina, Giselle
    Berrios-Cartagena, Nairimer
    Cordero-Hernandez, Jose M.
    Ortiz, Jose G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 354 - 354
  • [10] Extracts of Valeriana officinalis and neuroprotection against beta-amyloid neurotoxicity
    Santos, S. D.
    Malva, J. O.
    Macedo, T. R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 116 - 116